drugset / Trial / NCT04704843
A Study of Guselkumab in Adult Participants With Celiac Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of guselkumab compared to placebo in participants with celiac disease.
Timeline
- Start
- 2021-06-17
- Primary completion
- 2021-09-13
- Completion
- 2021-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | — | Intravenous |